Emerging Role of Calcium-Activated Potassium Channel in the Regulation of Cell Viability Following Potassium Ions Challenge in HEK293 Cells and Pharmacological Modulation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tricarico, Domenico ^a,b   Mele, Antonietta ^a,b   Calzolaro, Sara ^a,b   Cannone, Gianluigi ^a,b   Camerino, Giulia Maria ^a,b   Dinardo, Maria Maddalena ^a,b   Latorre, Ramon ^a,b   Conte Camerino, Diana ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; ACETAZOLAMIDE; BENDROFLUMETHIAZIDE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; DICLOFENAMIDE; ETHOXZOLAMIDE; HYDROCHLOROTHIAZIDE; IBERIOTOXIN; METHAZOLAMIDE; POTASSIUM ION; QUERCETIN; RESVERATROL; TETRYLAMMONIUM;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; EMBRYO; HUMAN; HUMAN CELL; HYPERKALEMIA; HYPOKALEMIA; NUCLEOTIDE SEQUENCE; POTASSIUM CURRENT; PROTEIN FUNCTION;

BENDROFLUMETHIAZIDE; CELL LINE; CELL SURVIVAL; CHARYBDOTOXIN; DICHLORPHENAMIDE; ETHOXZOLAMIDE; HUMANS; METHAZOLAMIDE; PEPTIDES; POTASSIUM; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; TETRAETHYLAMMONIUM;

EID: 84880484571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069551     Document Type: Article

References (35)

1. Pere AK, Lindgren L, Tuomainen P, Krogerus L, Rauhala P, et al. (2000) Beneficial effects of dietary magnesium and potassium on cardiac and renal morphologic features in cyclosporin A-induced damage in spontaneously hypertensive rats. Surgery 128: 67-75. doi:10.1067/msy.2000.106530. PubMed: 10876188.
2. Wang W, Soltero L, Zhang P, Huang XR, Lan HY, et al. (2007) Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. Am J Physiol Renal Physiol 293: F1123-F1130. doi:10.1152/ajprenal.00104.2007. PubMed: 17634402.
3. Oberleithner H, Callies C, Kusche-Vihrog K, Schillers H, Shahin V, et al. (2009) Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci U S A 106: 2829-2834. doi:10.1073/pnas.0813069106. PubMed: 19202069.
4. Clausen T, (2010) Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam Clin Pharmacol 24: 595-605. doi:10.1111/j.1472-8206.2010.00859.x. PubMed: 20618871.
5. McVeigh G, Fitzpatrick K, Maxwell P, Trinick T, (2005) Guidelines for the treatment of hyperkalaemia in adults.
6. Hayes J, Kalantar-Zadeh K, Lu JL, Turban S, Anderson JE, et al. (2012) Association of Hypo- and Hyperkalemia with Disease Progression and Mortality in Males with Chronic Kidney Disease: The Role of Race. Nephron Clin Pract 120: c8-c16. doi:10.1159/000329511. PubMed: 22156587.
7. Sai Naresh VV, Ramakrishna V, Ramakrishna P, Siva Kumar V, (2008) Hyperkalemia masking left ventricular hypertrophy in electrocardiogram in a patient with end-stage renal disease. Indian J Nephrol 18(1):: 22-23. doi:10.4103/0971-4065.41284. PubMed: 20368916.
8. Green D, Green HD, New DI, Kalra PA, (2013) The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease. Nephrol Dial Transplant 28(1): 99-105 doi: 10.1093/ndt/gfs129. Epub 2012 May 18.
9. Platt D, Griggs R, (2009) Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias. Curr Opin Neurol 22(5):: 524-531. doi:10.1097/WCO.0b013e32832efa8f. PubMed: 19571750. Review.
10. Tawil R, Ptacek LJ, Pavlakis SG, DeVivo DC, Penn AS, et al. (1994) Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann Neurol 35: 326-330. doi:10.1002/ana.410350313. PubMed: 8080508.
11. Cannon SC, (2010) Voltage-sensor mutations in channelopathies of skeletal muscle. J Physiol 588: 1887-1895. doi:10.1113/jphysiol.2010.186874. PubMed: 20156847.
12. Tricarico D, Camerino DC, (2011) Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies. Front Pharmacol 2:8 doi: 10.3389/fphar.2011.00008. Epub 2011 Feb 28.
13. Webster A, Brady W, Morris F, (2002) Recognising signs of danger: ECG changes resulting from an abnormal serum potassium concentration. Emerg Med J 19: 74-77. doi:10.1136/emj.19.1.74. PubMed: 11777886.
14. Tricarico D, Lovaglio S, Mele A, Rotondo G, Mancinelli E, et al. (2008) Acetazolamide prevents vacuolar myopathy in skeletal muscle of K(+)-depleted rats. Br J Pharmacol 154(1):183-190 doi: 10.1038/bjp.2008.42. Epub 2008 Mar 17.
15. Meyer T, Jurkat-Rott K, Huebner A, Lehmann-Horn F, Linke P, et al. (2008) Progressive muscle atrophy with hypokalemic periodic paralysis and calcium channel mutation. Muscle Nerve 37(1):: 120-124. doi:10.1002/mus.20825. PubMed: 17587224.
16. Plaster NM, Tawil R, Tristani-Firouzi M, Canún S, Bendahhou S, et al. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105: 511-519. doi:10.1016/S0092-8674(01)00342-7. PubMed: 11371347.
17. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, et al. (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90: 291-366. PubMed: 20086079.
18. Trudell RG, Kaiser KK, Griggs RC, (1987) Acetazolamide-responsive myotonia congenita. Neurology 37(3):: 488-491. doi:10.1212/WNL.37.3.488. PubMed: 3822145.
19. Cannon SC, (1996) Sodium Channel Defects in Myotonia and Periodic Paralysis. Annu Rev Neurosci 19: 141-164. doi:10.1146/annurev.ne.19.030196.001041. PubMed: 8833439.
20. Adrian RH, Bryant SH, (1974) On the repetitive discharge in myotonic muscle fibres. J Physiol 240(2):: 505-515. PubMed: 4420758.
21. Henney NC, Li B, Elford C, Reviriego P, Campbell AK, et al. (2009) A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts. Am J Physiol Cell Physiol 297(6):C1397-1408 doi: 10.1152/ajpcell.00311.2009. Epub 2009 Sep 23.
22. Chang H, Ma YG, Wang YY, Song Z, Li Q, et al. (2011) High glucose alters apoptosis and proliferation in HEK293 cells by inhibition of cloned BK Ca channel. J Cell Physiol 226(6):: 1660-1675. doi:10.1002/jcp.22497. PubMed: 21413024.
23. Jia X, Yang J, Song W, Li P, Wang X, et al. (2013) Involvement of large conductance Ca(2+)-activated K (+) channel in laminar shear stress-induced inhibition of vascular smooth muscle cell proliferation Pflugers Arch 465(2):: 2012-232. Epub 10.1007/s00424-012-1182-z. PubMed: 23179380.
24. Dinardo MM, Camerino G, Mele A, Latorre R, Conte Camerino D, et al. (2012) Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle. PLOS ONE 7(7):: e40235. doi:10.1371/journal.pone.0040235. PubMed: 22808126.
25. Tricarico D, Barbieri M, Camerino DC, (2000) Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis. Ann Neurol 48: 304-312. doi:10.1002/1531-8249(200009)48:3. PubMed: 10976636.
26. Tricarico D, Barbieri M, Mele A, Carbonara G, Camerino DC, (2004) Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats. FASEB J 18: 760-761. PubMed: 14766795.
27. Tricarico D, Mele A, Conte Camerino D, (2006) Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels. Neuromuscul Disord 16: 39-45. doi:10.1016/j.nmd.2005.10.005. PubMed: 16368240.
28. Krick S, Platoshyn O, Sweeney M, McDaniel SS, Zhang S, et al. (2002) Nitric oxide induces apoptosis by activating K+ channels in pulmonary vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 282(1):: H184-H193. PubMed: 11748062.
29. Burg ED, Remillard CV, Yuan JX, (2008) Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol 153 (Suppl 1) Suppl 1:: 2007-S111. Epub 18084317.
30. Treistman SN, Martin GE, (2009) BK channels: mediators and models for alcohol tolerance. Trends Neurosci 32: 629-637. doi:10.1016/j.tins.2009.08.001. PubMed: 19781792.
31. Kingston RE, Chen CA, Rose JK, (2003) Calcium phosphate transfection. Curr Protoc Mol Biol Chapter 9: 1. PubMed: 18265332.
32. Lippiat JD, Standen NB, Davies NW, (1998) Block of cloned BKCa channels (rSlo) expressed in HEK 293 cells by N-methyl D-glucamine. Pflugers Arch 436: 810-812. doi:10.1007/s004240050708. PubMed: 9716719.
33. Ghatta S, Nimmagadda D, Xu X, O'Rourke ST, (2006) Large-conductance, calcium-activated potassium channels: Structural and functional implications. Pharmacol Ther 110: 103-116. doi:10.1016/j.pharmthera.2005.10.007. PubMed: 16356551.
34. Nardi A, Olesen SP, (2008) BK channel modulators: A comprehensive overview. Curr Med Chem 15: 1126-1146. doi:10.2174/092986708784221412. PubMed: 18473808.
35. Orio P, Latorre R, (2005) Differential effects of beta 1 and beta 2 subunits on BK channel activity. J Gen Physiol 125: 395-411. doi:10.1085/jgp.200409236. PubMed: 15767297.